vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and WORKIVA INC (WK). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $238.9M, roughly 1.1× WORKIVA INC). WORKIVA INC runs the higher net margin — 4.9% vs 0.7%, a 4.2% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.5% vs -16.5%). WORKIVA INC produced more free cash flow last quarter ($50.7M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
HCM vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $238.9M |
| Net Profit | $2.0M | $11.8M |
| Gross Margin | 37.7% | 80.7% |
| Operating Margin | -13.2% | 3.3% |
| Net Margin | 0.7% | 4.9% |
| Revenue YoY | -16.5% | 19.5% |
| Net Profit YoY | -83.6% | 234.0% |
| EPS (diluted) | $0.00 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $238.9M | ||
| Q3 25 | — | $224.2M | ||
| Q2 25 | $277.7M | $215.2M | ||
| Q1 25 | $324.5M | $206.3M | ||
| Q4 24 | — | $199.9M | ||
| Q3 24 | — | $185.6M | ||
| Q2 24 | $305.7M | $177.5M | ||
| Q1 24 | — | $175.7M |
| Q4 25 | $2.0M | $11.8M | ||
| Q3 25 | — | $2.8M | ||
| Q2 25 | $455.0M | $-19.4M | ||
| Q1 25 | $11.9M | $-21.4M | ||
| Q4 24 | — | $-8.8M | ||
| Q3 24 | — | $-17.0M | ||
| Q2 24 | $25.8M | $-17.5M | ||
| Q1 24 | — | $-11.7M |
| Q4 25 | 37.7% | 80.7% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | 0.1% | 77.0% | ||
| Q1 25 | 48.0% | 76.6% | ||
| Q4 24 | — | 77.1% | ||
| Q3 24 | — | 76.5% | ||
| Q2 24 | 41.1% | 76.8% | ||
| Q1 24 | — | 76.4% |
| Q4 25 | -13.2% | 3.3% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | -1.3% | -10.3% | ||
| Q1 25 | -5.0% | -12.0% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | -9.0% | -13.0% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | 0.7% | 4.9% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | 163.8% | -9.0% | ||
| Q1 25 | 3.7% | -10.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | -9.2% | ||
| Q2 24 | 8.4% | -9.9% | ||
| Q1 24 | — | -6.7% |
| Q4 25 | $0.00 | $0.21 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | $0.52 | $-0.35 | ||
| Q1 25 | $0.01 | $-0.38 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | $0.03 | $-0.32 | ||
| Q1 24 | — | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $338.8M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $-5.4M |
| Total Assets | $1.8B | $1.5B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $338.8M | ||
| Q3 25 | — | $315.9M | ||
| Q2 25 | $1.4B | $284.3M | ||
| Q1 25 | $836.1M | $242.0M | ||
| Q4 24 | — | $301.8M | ||
| Q3 24 | — | $248.2M | ||
| Q2 24 | $802.5M | $267.9M | ||
| Q1 24 | — | $296.1M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $-5.4M | ||
| Q3 25 | — | $-36.9M | ||
| Q2 25 | $1.2B | $-66.5M | ||
| Q1 25 | $759.9M | $-75.7M | ||
| Q4 24 | — | $-41.7M | ||
| Q3 24 | — | $-50.8M | ||
| Q2 24 | $740.1M | $-77.7M | ||
| Q1 24 | — | $-83.2M |
| Q4 25 | $1.8B | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $51.0M |
| Free Cash FlowOCF − Capex | $3.4M | $50.7M |
| FCF MarginFCF / Revenue | 1.2% | 21.2% |
| Capex IntensityCapex / Revenue | 1.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.21× | 4.31× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $138.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $51.0M | ||
| Q3 25 | — | $46.2M | ||
| Q2 25 | $-72.9M | $50.3M | ||
| Q1 25 | $40.3M | $-7.4M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | — | $18.9M | ||
| Q2 24 | $-39.8M | $-14.0K | ||
| Q1 24 | — | $24.8M |
| Q4 25 | $3.4M | $50.7M | ||
| Q3 25 | — | $46.1M | ||
| Q2 25 | $-82.2M | $49.3M | ||
| Q1 25 | $32.5M | $-8.1M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | — | $18.7M | ||
| Q2 24 | $-49.9M | $-122.0K | ||
| Q1 24 | — | $24.6M |
| Q4 25 | 1.2% | 21.2% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | -29.6% | 22.9% | ||
| Q1 25 | 10.0% | -3.9% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | -16.3% | -0.1% | ||
| Q1 24 | — | 14.0% |
| Q4 25 | 1.8% | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 3.3% | 0.5% | ||
| Q1 25 | 2.4% | 0.4% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 4.21× | 4.31× | ||
| Q3 25 | — | 16.57× | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
WK
| License And Service | $219.3M | 92% |
| XBRL Professional Services | $16.4M | 7% |
| Other Services | $3.2M | 1% |
